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Abstract. Patients with Plasmodiuin falciparum infections were selected with an in vivo chloroquine sensitivity 
assay. Fourteen days after treatment, the gametocytes were studied in relation to asexual parasite responses classified 
as drug-sensitive or showing RI or RII resistance. Gametocyte prevalence and density appeared significantly higher 
in RII than RI strains and higher in RI than in sensitive strains. This finding on gametocyte variation in vivo may 
explain why the RII type of chloroquine resistance has became more prevalent than RI everywhere in tropical Africa 
in the short time since its emergence. The biological and epidemiologic advantage of chloroquine-resistant malaria 
mediated through gametocytes is discussed in the context of the present drug pressure in Africa. 
In the city of Dakar, Senegal, a hypoendemic area for 
malaria where chloroquine-resistant strains of Plasmodi- 
um falciparum have been detected since 1988l. and have 
now reached a prevalence of 45%, we studied gametocyte 
numbers among sensitive (S) and RI  and RI1 resistant par- 
asites. In vivo chloroquine sensitivity assays, at a standard 
dose of 25 mg of chloroquinelkg of body weight, distrib- 
uted over three days, were performed in 68 individuals 
(ages 2-70 years, mean 19.4, median 17) and blood slides 
were taken on days O, 2, 4, 7, and 14. Thick blood films 
were Giemsa-stained and 200 microscopic oil-immersion 
fields were examined (corresponding to about 0.5 p1 of 
b l ~ o d ) , ~  from which the gametocyte density was estimat- 
ed. The parasitologic incidence was low (about 0.6lper- 
sonlyear) .4 
Results were 42 chloroquine-sensitive responses (62%), 1 1 
RI (16%), and 15 RII (22%). The prevalence rates of P. fal- 
ciparum gametocytes in the three groups were similar on days 
O and 2; however, on days 4 and 7, resistant strains had double 
the rate of sensitive ones and on day 14, it was three times 
higher (Figure 1) (P  = 0.038 on day 4, P = 0.001 on day 7, 
and P < on day 14, by Fisher’s exact test). Combined 
data from days 7 and 14 showed that 30% of the patients with 
sensitive strains presented with gametocytes, as compared 
with 79% in patients with resistant strains (P  < by 
Fisher’s exact test); the relative proportions in RI and RII 
strains were 59% and 93%, respectively ( P  = 0.005, by Fish- 
er’s exact test). 
Gametocyte densities on days 4, 7 and 14 were lower in 
sensitive as compared with both RI and RII strains (Figure 
2). Combined data from days 7 and 14 showed that the geo- 
metric mean numbers of gametocytes from patients with sen- 
sitive, RI, and RII strains were, respectively, 0.7, 2.2, and 
12.61~1 of blood (for S-RI, S-RII, and RI-RI1 comparisons; 
P = 0.026, P < and P = 0.0006, respectively, by the 
Mann-Whitney U test). 
Although/therapeutic responses were linked with age (age 
S > RI > Ru; 21.8, 16.1, and 15.0 years old, respectively), 
a stratification in relation to age ruled out any influence of 
age on gametocyte prevalences and densities as measured by 
in vivo response. For children less than 15 years of age (n 
= 25), combined data from days 7 and 14 showed that ga- 
metocyte prevalences and densities of sensitive and resistant 
l 
i 
strains were significantly different (P  < by Fisher’s 
exact test for prevalences and P < by the Mann-Whit- 
ney U test for densities). A similar result was obtained for 
those 15 years of age and older (n = 43) ( P  = 0.002 by 
Fisher’s exact test and P = 0.002 by the Mann-Whitney U 
test). 
Chloroquine is not thought to induce P. falciparuin ga- 
metocyt~genesis~ or to interfere with transmission once ga- 
metocytes have appeared in the bloodstream6-8 despite the 
higher infectivity of chloroquine-resistant strains in the ro- 
dent parasites P.  berghei and P. yoelìi n i g e r i e a ~ i s . ~ .  l o  
Most studies of the response of P. falciparum to chlo- 
roquine have focused on asexual stages, with gametocyte 
responses rarely mentioned and not considered separately 
by the in vivo response. In areas of chloroquine resistance, 
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FIGURE 1. Evolution after treatment with chloroquine of game- 
tocyte prevalence in the blood of patients with falciparum malaria 
attacks. Asterisks indicate significant differences (P < 0.05, by Fish- 
er’s exact test) from sensitive (S) patients (n varied on the different 
days of testing between 40 and 42 for S patients, 10 and 11 for RI 
patients, and 13 and 15 for RI1 patients). R = resistant. 
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FIGURE 2. Evolution after treatment with chloroquine of the geo- 
metric mean gametocytemia,per microliter of blood on patients with 
falciparum malaria attacks (upper bars indicate the standard devia- 
tion). S = sensitive; R = resistant. 
data from Mozambique showed an increase in gametocytes 
on day 7 post-treatment, but this was not seen in Pun- 
Thorough observations on gametocytes are often difficult 
to extrapolate in terms of transmission, it is clearly estab- 
lished that gametocyte density is a critical factor in their 
infectivity to  anopheline^.^ Our observations suggest that 
when sensitive and RI or RII resistant strains coexist in a 
human population, the careful use of treatment with chlo- 
roquine leads to preferential transmission of the most resis- 
tant parasites. This may give a clue as to why the RI1 type 
of chloroquine resistance has became more prevalent than 
that of RI  everywhere in tropical Africa in the short time 
since its emergence. 
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